The Food and Drug Administration will be hosting its very first public hearing on CBD on May 31st on legalizing CBD in food and drinks.
Currently the FDA prohibits CBD from being added to food.
The meeting is also to find a way to regulate the newly legalized cannabis product.
It was this past December that President Trump signed the Farm Bill which legalized hemp-derived CBD.
The FDA wants data on CBD’s safety in food products and feedback on how it might regulate manufacturing, marketing and labeling, according to a notice this week in the Federal Register.
“It’s critical that we address these unanswered questions about CBD and other cannabis and cannabis-derived products to help inform the FDA’s regulatory oversight of these products — especially as the agency considers whether it could be appropriate to exercise its authority to allow the use of CBD in dietary supplements and other foods,” said outgoing FDA Commissioner Scott Gottlieb.
“This is a complicated topic and we expect that it could take some time to resolve fully,” he said. “Nevertheless, we’re deeply focused on this issue and committed to continuing to engage relevant stakeholders as we consider potential paths forward.”
“The FDA continues to be concerned about the proliferation of egregious medical claims being made about products asserting to contain CBD that haven’t been approved by the FDA, such as the products and companies receiving warning letters today,” Gottlieb said.
